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Concentrations ofhemopexin, a porphyrin-binding serum protein synthesized exclusively 
in the liver , increased significantly and concomitantly with levels of erythr ocyte and liver 
protoporphyrin and coproporphyrin in mice made porphyric with l o/l griseofulvin in the feed. 
Liver weights of porphyric mice increased remarkably. In comparision with controls, the 
ratio of the weight of normal to porphyric livers was at 10 days 1:2.1, at 21 days 1:2.8, and at 
46 days 1:3.8. This increase in liver size was accompanied by increased cell clivision. The 
hepatic hyperplastic tissue fragments survived in vitro for several weeks and could be 
subcultured. The cultured cells, like those of the original liver, showed intense protopor-
phyrin nuorescence in the cytoplasm. 
Hemopexin (Hx) is a serum protein which binds 
heme in a 1:1 molar ratio with a Kd of - 10 13 M [1 ] 
and binds certain other biologically occurring por-
phyrins with a K d of 10 " to 4 x 10- r M [2,3]. 
Hyperhemopexinemia is encountered in rabbits 
made porphyric by injections of allylisopropylace-
tamide (AlA) or diethyl-1 ,4-dihydro-2,4,6-trime-
thyl pyridine-3,5-dicar boxylate (DDC) l4]. Hx lev-
els become elevated up to 4-fold 48 to 72 hr after 
the first injection of AlA or DDC. 
Griseofulvin causes porphyria in mice and leads 
to the development of hepatomas [5]. Since serum 
Hx levels have been reported to be increased in 
man with malignancies [4,6), we investigated 
whether mice with hepatic hyperplasia caused by 
griseofulvin show comparable induction ofHx syn-
thesis. We correlated erythrocyte and hepatic por-
phyrins with Hx levels in serum and the degree of 
liver enlargement in relation to duration of griseo-
fulvin administration. In addition, we determined 
the subcellular localization of the porphyrin depos-
its in the liver tissues, their identity as protopor-
phyrin, and explored the ability of explanted por-
phyric liver cells t o grow (divide) and migrate in 
vitro. 
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MATERIALS AND METHODS 
Antmals 
Swiss-Webster a lbino 8-week-old mice weighing 20 
to 24 gm were used . Groups of 4 to 24 animals were 
made porphyric by feeding ad libitum 1 ~ micropulver-
ized griseofulvin added to powdered laboratory feed. 
Experimental Procedure 
Porphyrin content of erythrocytes and liuers . Treated 
a nd control mice were bled and sacrificed a t intervals 
up to 49 days. The size and weight of each liver was 
determined and the concentration of coproporphyrin 
a nd protoporphyrin in erythrocytes and liver were mea-
sured by the method of Rimington 17- 91. For histologic 
evalua tion, liver slices were stained with hematoxylin 
and eosin (H & El, with silver impregnation for reticu-
lum, and with Perl's stain for iron. Porphyric live rs a nd 
bone marrow were examined by fluorescence micro-
scopy 110- 11) to assess the site of pigment deposition. 
Hepat1c explants . The finding of a remarkable in-
crease in liver weight from porphyric mice prompted us 
to evaluate the ability of the porphyric liver cel ls to 
grow in tissue culture. Partial hepatectomies were per-
formed on 11-week-old mice killed by cervical disloca-
tion. Two livers from normal mice and two from those 
rendered porphyric by 21 days of griseofulvin intake 
were finely minced with scissors. The fragments were 
placed in 60-mm Falcon plastic Petri dishes under 
covers lips, in Eagle's minimum essential medium 112] 
to which 10% horse serum, penicillin (100 U/m)), and 
streptomycin (100 mg/m)) had been added. The livers 
were incubated at 36.5•c in a humidified atmosphere of 
5~ carbon dioxide and a ir. After 10 days, the covers! ips 
were removed. The medium was changed 3 times 
weekly. Migration of cells from the explants of the 
porphyric livers occurred by the second day and subcul-
tures were made after 3 weeks which survived for 8 
weeks. No further subcultures were performed. 
The subcultured cells were analyzed by both inverse 
light and fluorescence microscopy, as well as microfluo-
rospectrometry. They were examined unstained and 
stained with H & E after fixation in 10~ formalin 
110,13]. 
Feb.l977 
Comparison of serum hemopexin and porphyrin. con-
tent of erythrocytes and liuer. In a separate study, mice 
were rendered porphyric with griseofulvin and sacri-
ficed at 24 and 48 hr, and at 1, 3, and 7 weeks. The Hx 
levels were determined by a modified Mancini tech-
nique [14]. The immunologic cross-reactivity between 
rat and mouse Hx allowed determination of mouse pro-
tein with an antibody directed against that of rat ( 14]. 
Serum Hx concentrations were correlated with erythro-
cyte and liver protoporphyrin and coproporphyrin in 80 
porphyric and 20 control mice. Samples of serum and 
blood from 8- and 11-week-old control and porphyric 
mice were examined by routine hospital analysis for 
chemistry (SMA-12) and hemogram (SMA-4). 
RESULTS 
The livers of the porphyric mice increased re-
markably in size. The ratio of mean control to 
porphyric liver weight after 10, 21, and 46 days 
was 1:2.1, 1:2.8, and 1:3.8 respectively (Tab. 1). 
Liver slices stained with H & E showed many cells 
to be binucleated and to contain brown protopor-
phyrin pigment, mainly deposited around en-
larged and proliferated bile canaliculi and in 
K upffer cells. Fluorescence microscopy showed dif-
fuse fluorescence of the cytoplasm, maximal in the 
areas of brown pigment within 1i ver cells and par-
ticularly accumulated around the bile ducts (Fig. 
1). 
After 1 day of griseofulvin intake, livers of 
treated mice showed an increase in porphyrins 
over those of controls (Tab. II) . Mter the third day, 
the porphyrin content of circulating erythrocytes 
in treated mice had begun to rise, reaching a 
maximum concentration at approximately 21 days 
with a mean of 1848~-tg/ 100 ml packed red cells. At 
this time, all erythrocytes fluoresced to a vary]ng 
degree (but not normoblasts). The mean liver pro-
toporphyrin content was 251 J.Lg/gm wet weight at 
21 days and continued to increase to 415 J.Lg/gm 
wet weight at 46 days. 
Migration of cells from the explant of porphyric 
hepatic tissue into the medium began on the sec-
ond day, as illustrated for day 10 in Figure 2. 
Subcultures made after 3 weeks surv]ved for 2 
months. Under the same conditions the control 
liver cells from the explant showed migration of 
some fibroblasts which did not survive after 10 
days. Cultures from the porphyric liver showed 
two cell types which were identified by H & E-
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stained light microscopy as fibroblasts and hepato-
cytes, the latter, containing brown pigment gran-
ules, was often binucleated, a fmding similar to 
the original porphyric liver. At 6 weeks one of the 
subcultures of a porphyric liver was examined by 
fluorescence microscopy. Fluorescence was mini-
mal in the fibroblasts, but intense in the cells 
containing brown pigment (Fig. 3). Identification 
of the fluorescence spectrum by microfluorospec-
trometry indicated a peak emission of 637 run 
which corresponds to a protoporphyrin maximum 
of 6366 A reported by Rung [13]. 
Routine analysis of serum and blood showed no 
anemia for mice on 1% griseofulvin compared to 
control groups after 3 weeks. However, at this 
time a routine hospital chemistry survey revealed 
an increase in total bilirubin (2.3 j.tg{% vs 1.2 
J.Lgo/o), alkaline phosphatase (50 KA vs 12 KA 
units), and SGOT (250 Karmen vs 147 Karmen 
units) in treated over control mice. 
Table Ill shows the mean level of serum Hx and 
erythrocyte protoporphyrin and coproporphyrin 
for 5 experimental groups and 1 control group. We 
found a positive correlation between Hx concen-
tration and the log of the protoporphyrin content, r 
= 0.954 and p < 0.01 . SimiJarly, a linear correla-
tion existed between Hx levels and the copropor-
phyrin content, r = 0.974 and p < 0.01. 
DISCUSSION 
Hurst and Paget [5] reported the frequent occur-
rence of multiple hepatomas for mice fed on griseo-
fulvin when autopsied at 400 to 435 days. For 
example, in 13 mice fed on a 1% diet for 435 days, 
10 carried macroscopic hepatomas, up to 20 in 
number and 3 em in diameter. On a 0.5% diet, 
hepatomas were less numerous but present in 5 of 
20 mice. Microscopic examination of the liver 
showed in some cases hepatocytes with double nu-
clei , enlarged nuclei, or numerous mitoses. The 
bile ducts were enlarged and many new bile ducts 
formed , around which brown pigment was depos-
ited. The pigment was initially recognized to be 
protoporphyrin by DeMatteis and Rimington ( 15). 
The mouse as an animal model for protoporphyria 
has subsequently been reported by a number of 
authors [15-231 and offers an intrigu]ng compari-
son with human diseases such as erythropoietic 
TABLE I. Liucr weights of porphyric and control mice" 
Liver weight in grams 
Number of days 
Griseofulvin treated Control p" 
0 1.148 ± 0.055 (16)'" 
10 2.826 ± 0.231 (10) 1.362 ± 0.146 (8) <0.001 
21 4.112 ± 0.443 (6) 1.489 ± 0.110 (6) < 0.001 
46 6. 767 ± 0.526 (11) 1. 794 ± 0.052 (9) < 0.001 
" The mice used for experiments were B weeks old. The results are expressed as mean ± standard error. 
1
' The means are compared by Student's t-test; to obtain the value ofp, a degree of freedom , N, + N2 - 2 has been 
used throughout. 
·· The figures in parentheses indicate the number of animals. 
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FIG. 1. Protoporphyrin fluorescence in and around an enlarged bile duct in a hypertrophied liver noduJe from a 
mouse treated with griseofulvin for 21 days. 
FIG. 2. Migration of liver cells into the medium, 10 days after initiation of tissue culture. The explant was 
derived from a liver nodule of a mouse treated for 46 days with griseofulvin. Brown granules in cytoplasm of 
hepatocytes represent protoporphyrin. 
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TABLE II. Porphyrin content of erythrocytes and livers of mice on griseofulvin" 
Griseofulvin Number of 
treatment mice Coproporphrin Protoporphyrin Coproporphyrin Protoporphyrin 













7.1 (0-14.4) 53 (20- 116) 0.07 (0.016-0.134) 0.24 (0.02-0.53) 
2.1 (0-8.3) 58.6 (35.2-89.6) 0.22 (0.13- 0.36) 0.79 (0.19- 1.60) 
11.1 (6.5- 16.4) 131.8 (63.0-238.0) 2.6 (0.95-8.00) 68.8 (1.8- 96.0) 
16.8 (1.0-66.0) 234 (40-495) 3.34 (0.38-7.80) 106.0 (50.7-174.0) 
18.7 (10.9-31.6) 597 (272-925) 2.2 (0.5-7.45) 135 (76-272) 
20 
6 
22.4 (4.9-53.6) 1848 (693-4270) 4.7 (2.2-11.5) 251 (159-478) 
41.0 (20.5-76.2) 1248 (784-1880) 6.0 (2.8-11.5) 415 (167-653) 
" The results are expressed as mean; the range is indicated in parentheses. 
TABLE III. S erum hemopexin. and erythrocyte porphyrins of porphyric mice" 
Serum Erythrocyte 
Status of mice Number of mice Hemopexin Protoporphyrin Coproporphyrin 
( f.IIJ/100 ml) ( f.IIJ/100 ml) ( mg/100 ml) 
Control 20 113.25 = 4.48 17.47 ± 2.03 1.46 ± 0.50 
1 day porphyric 7 163 ± 13.32 39.20 ± 6.15 6.06 ± 0.65 
2 days porphyric 19 187.89 ± 15.93 55.12 ± 8.38 10.22 ± 2.04 
1 week porhyric 24 224.92 ± 9.26 544 .31 ± 84.67 10.50 ± 1.66 
3 weeks porphyric 24 281.71 ± 22.03 1902.96 ± 270.55 20.65 ± 2.07 
7 weeks porphyric 6 233.33 ± 30.55 913.50 ± 239.0 13.09 ± 2.16 
'' The results are expressed as mean ± standard error. 
protoporphyria where the primary site of por-
phyrin synthesis, whether in the liver and/or th e 
bone marrow, remains to be clarified 110,11,24,25]. 
In our study, the remarkable effect of griseoful-
vin to cause hepatic hyperplasia is demonstrated 
by the s ignificant increase in liver weights shown 
in Table I. An increase in cell size and number , in 
agreemen t with Janousek 1171, accounts for the 
major pa rt of this enlargement. Concomitant with 
the liver enlargement, serum o, fetoprotein levels 
increased from 0.035 ng/ml to 0.111 ± 0.016 at 1 
week and 0.331 ± 0.133 at 3 weeks on griseoful-
vin.* The growth in cell size appears to be due, in 
part, to proliferation of bile ducts. Deposition of 
pigment a round the bile ducts may be a conse-
quence of the low solubility of protoporphyrin in 
bile [5,11 1, leading to biliary obstruction, and 
could reflect a limited capacity of the liver to ex-
crete this pigment. 
The porphyrin content in the liver was already 
increased within a day and continued to rise 
through 46 days of treatment (Tab. li) . This find-
ing is in agreement with earli er studies by Nakao 
et al 1181, J anousek ll71, and more recently by 
Matilla and Molland [23]. The erythrocyte por-
phyrin also increased within a few days, was 
maximal approximately 3 weeks after griseofulvin 
intake, and may be h epatic in origin. 
The surprising ease of porphyric liver cell sur-
* Dr. Dr. Stewart Sell kindly performed these assays. 
viva] in tissue culture is demonstrated in Figures 
2 and 4. Two types of cells were seen, fibroblasts, 
which did not have brown pigment and only slight 
porphyr in fluorescence, and hepatocytes, which 
contained brown pigment deposits on H & E stain-
ing (Fig. 4) a nd corresponding protoporphyrin flu-
orescence limited to the cytoplasm. Cells were of-
ten binucleated similar to t hose of th e original 
liver, a finding supported by pre viou s observations 
[51. The cells were not examined bv electronmi-
croscopy and Kupffer cells were n~t specifically 
identified . Survival of liver cells in culture has 
been reported previous ly by such investigators as 
Borek 1261, Oshiro et al [27], and more recently by 
Mondal 128], who reported transformed liver cells 
obtained in culture from hepatectomized rats 
treated with dimethylnitrosamine. 
Hx, a porphyrin-binding serum protein, is syn-
thesized exclusively in the liver 129-311. Strik-
ingly, in mice rendered porphyric \vi th griseoful-
vin, Hx concentrations rise concomitantly with 
increasing liver and erythrocyte porphyrin content 
(Tabs. ll, ill). They are also elevated in rabbits 
and rats in response to a variety of inducing 
agents including porphyrinogenic drugs like AlA 
and DDC. On the contrary, in human hepatic 
porphyria cutanea tarda and erythropoietic proto-
porphyria l32- 34], Hx levels can be reduced, al-
though not to the degree encountered in hemolytic 
diseases l35-371. Albumin binds protoporphyrin 
[3] equally a s well as does Hx and further studies 
FIG. 3. Fluorescence microscopy of protoporphyrin in hepatocytes in tissue culture. Fluorescence was limited to 
cytoplasm. Details in legend to Fig. 2 
Ftc. 4. Brown pigment deposition, H & E stain, corresponding to protoporphyrin in hepatocytes in tissue 
culture. Details in legend to Fig. 2 
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are necessary to elucidate the function of these two 
proteins in health and disease. Various factors 
appear to control Hx synthesis in experimental 
and human porphyrias, for example DDC and gri-
seofulvin which cause protoporphyrin accumula-
tion [38,39] may exert a secondary effect on the 
content or distribution of hepatic heme. 
Facilitation ofHver cells migrating into culture 
medium by griseofulvin administration may prove 
to be a useful model for parenchymal liver cell 
propagation and possibly as an in vitro system to 
test the efficacy of drugs and hormones effecting 
the production of porphyrin. No metabolic per-
formances of the cells were studied. It is not 
known whether the porphyrin accumulated in the 
hepatic cells in tissue culture were residues or 
whether the cells were actively synthesizing por-
phyrin, which is perhaps less likely in view of the 
observations of De Matteis and Gibbs [22] who 
reported inhibition of mitochondrial chelatase in 
liver cells with griseofulvin so long as the drug 
was available. Since the present study was com-
pleted, Hx production has been observed to be 
substantial in cultures of human liver fragments 
[33] and rat liver cell suspensions [40] as well as 
fetal rat liver cell cultures [ 41]. In this latter sys-
tem, Hx production appeared to be equally as 
well correlated to liver cell multiplication as a,-
fetoprotein . Testing the ability of human hepato-
cytes to multiply, in response to this drug, seems 
indicated in view of its prolonged administration 
to children. In adults the detectable increase in 
porphyrin metabolism was barely significant dur-
ing treatment for chronic fungal infections [8]. 
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